ArriVent BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVBP and other ETFs, options, and stocks.

About AVBP

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. 

CEO
Zheng Bin Yao
CEOZheng Bin Yao
Employees
52
Employees52
Headquarters
Newtown Square, Pennsylvania
HeadquartersNewtown Square, Pennsylvania
Founded
2021
Founded2021
Employees
52
Employees52

AVBP Key Statistics

Market cap
688.05M
Market cap688.05M
Price-Earnings ratio
-8.41
Price-Earnings ratio-8.41
Dividend yield
—
Dividend yield—
Average volume
143.63K
Average volume143.63K
High today
$20.80
High today$20.80
Low today
$19.69
Low today$19.69
Open price
$19.69
Open price$19.69
Volume
230.14K
Volume230.14K
52 Week high
$36.37
52 Week high$36.37
52 Week low
$15.47
52 Week low$15.47

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AVBP. This list is generated using Robinhood data, and it’s not a recommendation.
Eli Lilly
Viking Therapeutics
Robinhood Markets
NVIDIA
SoundHound AI
Palantir Technologies
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.